Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
162M
-
Number of holders
-
222
-
Total 13F shares, excl. options
-
164M
-
Shares change
-
+548K
-
Total reported value, excl. options
-
$727M
-
Value change
-
+$3.48M
-
Put/Call ratio
-
0
-
Number of buys
-
107
-
Number of sells
-
-111
-
Price
-
$4.43
Significant Holders of IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK (IRWD) as of Q4 2024
264 filings reported holding IRWD - IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK as of Q4 2024.
IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK (IRWD) has 222 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 164M shares
.
Largest 10 shareholders include BlackRock, Inc. (23M shares), VANGUARD GROUP INC (19.5M shares), Sarissa Capital Management LP (16.4M shares), Pacer Advisors, Inc. (11.7M shares), ARMISTICE CAPITAL, LLC (9.47M shares), RENAISSANCE TECHNOLOGIES LLC (9.07M shares), STATE STREET CORP (8.33M shares), BRAIDWELL LP (5.44M shares), Kynam Capital Management, LP (4.69M shares), and LSV ASSET MANAGEMENT (4.08M shares).
This table shows the top 222 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.